Stay updated with breaking news from Lpcn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 6.3 % Shares of Lipocine stock opened at $3.85 on Friday. The company has a market capitalization of $20.47 million, a […]
By Colin Kellaher Shares of Lipocine moved higher in premarket trading Thursday after the biopharmaceutical company said it struck a potentially lucrative...
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 1.5 % NASDAQ:LPCN opened at $2.56 on Tuesday. Lipocine has a 12 month low of $2.31 and a 12 month high […]
Lipocine Inc. (NASDAQ:LPCN – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $2.64 and traded as high as $2.73. Lipocine shares last traded at $2.73, with a volume of 9,265 shares. Analysts Set New Price Targets Separately, StockNews.com […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Monday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ LPCN opened at $2.41 on Monday. Lipocine has a 52 week low of $2.31 and a 52 week high of […]